Clinical Trial Update: SAMe to Treat Biliary Cirrhosis Symptoms [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating SAMe (S-adenosyl-L-methionine) for biliary cirrhosis symptoms was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cirrhosis

Drugs mentioned

• SAMe (S-adenosyl-L-methionine)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Liver Cirrhosis, Biliary | Phase 2 | Status: TERMINATED